More harm than good: when drugs are removed from the market
Many approved drugs are often removed from sale because their benefit to harm ratio is not acceptable. Research published today in BMC Medicine has investigated… Read more »
Joel Lexchin received his MD from the University of Toronto in 1977. He is currently a Professor in the School of Health Policy and Management at York University in Toronto Canada where he teaches health policy. In addition, he has worked in the emergency department at the University Health Network also in Toronto for 28 years.
Latest posts by Joel Lexchin (see all)
- More harm than good: when drugs are removed from the market - 4th February 2016